Xenon Pharmaceuticals (XENE) has an average rating of buy and mean price target of $80.74, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Price: $63.62, Change: $-0.93, Percent Change: -1.44%
Century Aluminum (CENX) reported Q2 adjusted earnings late Thursday of $2.46 per diluted share, up from $0.30 a year earlier.Three analysts polled by FactSet expected $2.33.Revenue for the three months ended June 30 rose to $752.1 million from $628.1 million a year earlier.Four analysts surveyed by FactSet expected $817.2 million.The company's shares rose 1.6% in after-hours trading.
JFrog (FROG) reported Q2 non-GAAP earnings late Thursday of $0.27 per diluted share, up from $0.18 a year earlier.Analysts polled by FactSet expected $0.24.Revenue in the three months ended June 30 rose to $163.8 million from $127.2 million a year earlier.Analysts projected $155.6 million.The company expects Q3 non-GAAP EPS of $0.22 to $0.24 on revenue of $164 million to $166 million. Analysts project EPS of $0.22 on revenue of $159 million.JFrog boosted full-year guidance to non-GAAP EPS of $0.96 to $1.00 on revenue of $648 million to $652 million. The prior forecast was EPS of $0.93 to $0.97 on revenue of $628 million to $632 million.Analysts expect EPS of $0.95 on revenue of $632.9 million.JFrog shares jumped 13% in after-hours trading.
Reinsurance Group of America (RGA) reported Q2 adjusted earnings late Thursday of $8.89 per diluted share, up from $4.72 a year earlier.Analysts polled by FactSet expected $6.50.Revenue in the three months ended June 30 rose to $6.64 billion from $5.6 billion a year earlier.Analysts projected $6.67 billion.The company's shares rose 1.6% in after-hours trading.